Currently, there are no approved therapies for Stargardt disease, the most common inherited macular dystrophy, which is caused by biallelic mutations in the ABCA4 gene. However, multiple promising strategies are under active investigation. This article reviews recent advances in the therapeutic pipeline for STGD.
Retinal Physician
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.
Testimony from former CDC leadership highlighted differences with federal health officials on the process for reviewing and implementing vaccine policies.